Drreddys Laboratories | RDY - Current Assets


Drreddys Laboratories reported INR3.31B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
ANI Pharmaceuticals USD 747.08M 6.03M Mar/2026
Aurora Cannabis CAD 445.84M 22M Dec/2025
Bayer EUR 35.3B 2.39B Mar/2026
Canopy Growth CAD 524.67M 78.85M Dec/2025
Cipla INR 249.18B 16.3B Sep/2025
Corcept Therapeutics USD 426.03M 59.43M Mar/2026
Drreddys Laboratories INR 3.31B 164.26M Dec/2025
GlaxoSmithKline GBP 17.76B 251M Mar/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Lonza CHF 8B 3.41B Dec/2025
Novartis USD 26.61B 3.85B Mar/2026
Pacira USD 514.96M 33.01M Mar/2026
Phibro Animal Health USD 894.07M 31.88M Mar/2026
Prestige Brands USD 431.48M 1.94M Mar/2026
Richter Gedeon HUF 772.16B 39.24B Dec/2025
Sun Pharmaceuticals INR 601.36B 75.42B Sep/2025
Supernus Pharmaceuticals USD 731.58M 87.4M Mar/2026
Teva Pharmaceutical Industries USD 13.71B 236M Mar/2026